Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.
Market Analysis and Insights: Global Equine Healthcare Market
Due to the COVID-19 pandemic, the global Equine Healthcare market size is estimated to be worth US$ 1282.1 million in 2021 and is forecast to a readjusted size of US$ 1282.1 million by 2028 with a CAGR of 1.8% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Equine Healthcare global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
The top 13 manufacturers held about 75.03% of the market share in 2019.
Global Equine Healthcare Scope and Market Size
The global Equine Healthcare market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Equine Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Equine Diagnostic Products
Equine Therapeutic Products
Equine Supplement Products
Segment by Application
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Ceva Animal Health
Dechra Veterinary Products
Purina Mills
Norbrook Equine
Virbac
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Market Analysis and Insights: Global Equine Healthcare Market
Due to the COVID-19 pandemic, the global Equine Healthcare market size is estimated to be worth US$ 1282.1 million in 2021 and is forecast to a readjusted size of US$ 1282.1 million by 2028 with a CAGR of 1.8% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Equine Healthcare global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
The top 13 manufacturers held about 75.03% of the market share in 2019.
Global Equine Healthcare Scope and Market Size
The global Equine Healthcare market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Equine Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Equine Diagnostic Products
Equine Therapeutic Products
Equine Supplement Products
Segment by Application
Veterinary Hospitals and Clinics
Retail Pharmacies and Drug Stores
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Ceva Animal Health
Dechra Veterinary Products
Purina Mills
Norbrook Equine
Virbac
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.